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Abstract
Purpose To analyse short-term variability of systemic
blood pressure and choroidal blood flow in glaucoma
patients, and compare them with ocular hypertensive
patients and controls.
Subjects and methods Thirty untreated patients with primary
open-angle glaucoma (POAG), 25 untreated patients with
ocular hypertension (OHT) and 50 healthy controls without
local therapy were included in the study. Continuous 5-minute
measurements of arterial systemic blood pressure (SBP) by
Finometer and choroidal blood flow (CBF) by laser Doppler
flowmetry were obtained. Variability of SBP and CBF was
analysed by means of coefficient of variation and analyzed in
ANOVA model. Linear regression analysis was performed on
parameters of morphological (nerve fiber layer thickness) and
functional glaucomatous damage (visual field) on one side,
and between SBP and CBF on the other side.
Results ANOVA model demonstrated significant differences
in variability between the groups (p=0.003); post-hoc analysis
specified a significantly higher short-term variability of both
the blood pressure and choroidal blood flow in POAG patients
(coefficients of variation: 3.33%±1.05% and 3.90%±2.17%
respectively) than in healthy controls (coefficient of variation:
2.57%±0.80% and 2.94%±1.52% respectively). No signifi-
cant differences were found for OHT patients.
Conclusions POAG patients without local therapy demon-
strate an increased short-term BP and CBF variability.
Keywords Glaucoma . Short-term variability . Blood
pressure . Choroidal blood flow
Introduction
Ocular perfusion pressure (OPP) is an important component in
the pathogenesis of glaucomatous optic neuropathy (GON)
[1]. Not only low mean ocular perfusion pressure [1–6], but
also its variability play an important role in pathogenesis of
GON [7–11]. Since OPP depends on intraocular pressure
(IOP) and blood pressure in ocular vessels, their fluctuation
could also be regarded as a risk factor for GON. Indeed,
there are several studies indicating long-term and circadian
IOP variability as a separate risk factor for GON [12–14].
With regard to blood pressure (BP) variability in particular, a
number of studies have confirmed unstable or low BP as a
factor in GON development [4, 9–11, 15, 16]. However, all
observations with regard to BP refer either to so-called
“night dipping” [11, 16–18] or to average low systemic BD
[2, 19]. Moreover, most of the investigations dealing with
ocular perfusion variability in GON patients investigated
middle- and long-term ocular blood flow [8, 20–22], whereas
ischemia/reperfusion damage, postulated as one of the
pathogenetical mechanisms for GON [7], takes place on a
shorter time scale. In line with the hypothesis that ischemia/
reperfusion damage plays an important role in the patho-
physiology of glaucoma, and that such damage occurs due to
short-term disturbances to ocular perfusion, in our present
study we analysed short-term variability of SBP and CBF in
glaucoma patients, and compared them with ocular hyper-
tensive patients and controls.
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Subjects and methods
Subjects
Consecutive primary open-angle glaucoma (POAG)
patients and patients with ocular hypertension (OHT) were
recruited for the study from glaucoma consultations at the
University Eye Clinic Basel. The tenets of the Declaration
of Helsinki were followed. After approval by the ethics
committee, we obtained informed consent from our
subjects. Newly diagnosed and therapy-naive POAG and
OHT patients meeting study criteria underwent study
examinations; patients on IOP-lowering therapy were first
subjected to a 4-week wash-out phase. Healthy controls
were recruited through ads in local newspapers. Subjects
were screened for ocular and systemic diseases. A detailed
medical and ophthalmic history was recorded, and all
subjects completed an ophthalmological examination, in-
cluding IOP daily profiling (IOP readings were taken at 8 a.
m., 11 a.m. and 4 p.m.). POAG was diagnosed based on
glaucomatous optic disc cupping (in particular, thinning of
the inferior and/or superior rim, cup-to-disc ratio asymme-
try of >0.2), and based on matching glaucomatous visual
field defects [23]. Native IOP was neither an exclusion nor
an inclusion criterion for POAG diagnosis; hence, patients
from both the “high tension” and “normal tension” side of
the IOP spectrum in POAG were included. In contrast, at
least two daily readings of naive IOP of ≥21 mmHg, in
absence of disc or visual field damage, were required for
the diagnosis of OHT. All participants with diabetes
mellitus, history of essential hypertension, untreated or
unstable hypercholesterolemia, drug or alcohol abuse,
history of eye surgery except pseudophakia, high ametropia
(spherical equivalent < -5 diopters or > +3 diopters),
astigmatism above 2 diopters, significant cataract, pigment
or PEX dispersion syndrome, history of an acute glaucoma
attack, or any form of secondary glaucoma were excluded
from the study. Smoking was an exclusion criterion. In the
POAG group, an eye with the most advanced damage
(higher mean VF defect and thinner peripapillary RNFL as
demonstrated by ocular coherence tomography) was select-
ed, in the OHT group an eye with the higher mean diurnal
IOP was selected, and in healthy controls one randomly
selected eye per subject entered the analysis.
Systemic blood pressure
Blood pressure was measured by the Finometer device,
version 1.21 (FMS, Finapres Medical Systems BV, Arnhem,
The Netherlands) [24]. This device measures non-invasively
the blood pressure in the finger. As the finger arterial
pressure may differ from intra-brachial pressure, pulse shape
differences are removed by applying a generalized waveform
filter. Pressure level differences are corrected by a general-
ized level correction equation using filtered systolic and
diastolic levels and by level calibration, which uses an
additional return-to-flow systolic pressure measurement on
the ipsilateral upper arm for an individual calibration of the
reconstructed brachial pressure. It measures the brachial
pressure in a traditional way, and corrects the finger pressure
accordingly. The device allows continuous measurement of
blood pressure, with a sampling rate of 100 per second.
According to Guelen et al. [24], the calculated estimations
deviate from the intra-arterially measured intra-brachial
blood pressure values by -1.1 ± 10.7, -0.2 ± 6.8 and -1.5 ±
6.6 mmHg for the systolic, diastolic, and mean blood
pressure respectively. All the measurements were arbitrarily
taken on the third digit of the left hand. The device, having a
sampling rate of 100 Hz, effectively estimates the mean
blood pressure; hence, the parameters of BP variability refer
to the mean arterial blood pressure.
Submacular choroidal blood flow
Submacular choroidal blood flow was determined using a
method based on the laser Doppler flowmetry technique.
Compact laser Doppler choroidal flowmeter was applied
(IRO, Sion, Switzerland) [25].The optical system is based
on a confocal arrangement. A polarised laser source (λ=
785 nm, 100 m) is relayed with a 1:1 optical system (laser
beam at the cornea: width =1.3 mm, power =90 µW) and
focused at the subject’s retina (spot in the retinal image
plane =10–20 µm in diameter, optical thickness of confocal
layer =300 µm). The point laser source, the point of
illumination of the fovea, and the detecting optical fibre are
located in conjugated planes. The scattered light is collected
by an optical system organised with six fibres arranged
circularly around the central fixation point along a circle of
diameter of 180 µm (within the avascular zone of the
fovea). The photocurrent from the photodetector is Fourier
transformed and the haemodynamic parameters flow (more
precisely, flux), volume, and velocity are processed. As for
optic nerve laser Doppler flowmetry, each parameter varies
linearly with respect to changes in blood flow.
The subjects fixated the red light spot within the ocular,
and adjusted the focus by turning the ocular. The ocular to
cornea distance was set between 1.5 and 2 cm. A constant
very low level artificial room illumination was used
throughout all the experiments. A stable DC during a
recording was used as a criterion of proper fixation. DC
represents a “direct current” expressed in volts, and it is a
measure of the overall amount of light returning from the
eye to the photodetector. An unstable fixation during the
blood flow measurement is directly reflected in the amount
of returning light, and thus in the DC level [26]. Variations
of DC on the average throughout the recording of >10%
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were arbitrarily chosen as an exclusion criterion due to
inability to fixate.
Visual field and retinal nerve fibre layer (RNFL) thickness
In addition, visual field was assessed with OCTOPUS 101
(Haag Streit International, Switzerland) and retinal nerve
fiber layer thickness measured by means of Stratus OCT
(Carl Zeiss Meditec, Germany). Mean peripapillary RNFL
thickness was analyzed.
Experimental procedures
After evaluation of inclusion criteria, LDF measurement and
BP were performed simultaneously. One eye per subject
entered the analysis. Participants were instructed to abstain
from a large meal, coffee, alcohol consumption (including
alcohol-containing products and drugs), and physical exercise
for 24 h prior to the measurements. On the day of the
experiments, the subjects were seated for 30 min in the
laboratory. After stabilisation of BP during the next 5 minutes,
recordings of arterial blood pressure and submacular
choroidal blood flow were taken. Ten times 20-second
recordings, interrupted by 10-second breaks, were taken
during these 5 minutes. The 20 seconds of data were
arbitrarily collapsed to one mean value, producing a total of
ten values during 5 minutes. Variability of these ten values,
expressed as a coefficient of variation, was analyzed. This was
done for the LDF parameter “Flow” as well as for the mean
arterial BP estimated with Finometer.
Data analysis
Variability of BP and CBF was expressed as a coefficient of
variation (coefficient of variation = standard deviation/
mean x 100%). A two–way ANOVA model, with grouping
(POAG vs OHT vs controls) as one, and SBP- vs CBF-
variability as the second factor, was applied. Linear
regression analysis was performed between parameters of
morphological (RNFL thickness) and functional damage
(visual field mean defect) on one side, and BP/CBF
variability on the other side. Linear regression analysis
was also performed between the variability of SBP and
CBF in the POAG group, and between the mean IOP and
the variability parameters separately in the POAG and in
the OHT group.
Results
Thirty patients with primary open-angle glaucoma (POAG)
and 25 patients with ocular hypertension (OHT) were
consecutively recruited for the study. Age and gender of
subjects/patients are presented in Table 1, and other
relevant parameters in Table 2.
Variability parameters are presented within Table 2 and
in Fig. 1. The two-way ANOVA model showed significant
differences in parameter variability between the three
groups (p=0.003); post-hoc analysis with the Scheffe test
revealed a significantly higher short-term variability of both
the blood pressure and choroidal blood flow in POAG
Table 1 Demographics, age (in years) and gender distribution
Men Women
POAG (n=30) 62.4±7.4 n=15) 58.6±8.8 (n=15)
OHT (n=25) 57.3±8.8 (n=11) 58.2±9.1 (n=14)
Healthy controls (n=50) 59.5±9.4 (n=27) 57.4±8.7 (n=23)
Table 2 Descriptive statistics: best-corrected visual acuity, intraocular pressure (native), mean nerve fibre layer thickness, visual field mean
defect, mean blood pressure, coefficient of variability of choroidal blood flow and mean blood pressure across groups
BVCA IOP
(mmHg)
RNFL
(micrometers)
VF MD
(dB)
Mean BP
(mmHg)
CV CBF
(%)
CV BP
(%)
POAG (n=30) 1.0±0.19 17.6±4.8 80.8±17.6 2.1±2.1 99.7±11.2 3.90±2.17 3.33±1.05
OHT (n=25) 1.07±0.14 20.2±4.0 92.8±11.3 0.1±1.2 104.0±11.0 3.49±2.25 2.86±1.21
Healthy controls (n=50) 1.07±0.10 13.7±2.7 100.3±11.9 0.7±1.6 100.8±13.2 2.94±1.52 2.57±0.80
0
1
2
3
4
5
6
7
POAG OHT controls
Coefficient of 
Variabilty - CV (%)
Scheffé p=0.004
CV of choroidal blood flow
CV of arterial BP
p=0.017
Fig. 1 Short-term variability of both the blood pressure and choroidal
blood flow in POAG patients, in patients with OHT and in healthy
controls
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patients than in healthy controls (Scheffe p=0.004). In
ocular hypertensives, the variability values were statistically
equidistant from both the healthy controls (Scheffe p=0.28)
and POAG patients (Scheffe p=0.33). Coefficients of
variations are relative numbers, and can be directly
compared: the variability of choroidal blood flow was on
the average higher than the variability of arterial blood
pressure across all three groups (SBP- vs CBF-variability as
the second factor: p=0.017). Within the POAG group
alone, the correlation of BP and CBF variability on one side
and the visual field MD, peripapillary RNFL, and mean
IOP recordings on the other side was not significant (all six
p-values >0.14). Also, the two parameters of variability
correlated neither with each other in the POAG group (r=
-0.09, p=0.65) nor in all groups taken together (r=0.09, p=
0.35). In the OHT group, mean diurnal IOP did not
correlate with the CBF/BP variability (r=-0.09, p=0.69
and r=-0.05, p=0.79 respectively).
Discussion
The concept of ischemia/reperfusion damage has been
previously described [7]: the amount of free oxygen
radicals increases in the reperfusion phase after ischemia
[27]. The combination of increased nitric oxide and
superoxide (mostly produced in the mitochondria of the
axons) results in formation of a neurotoxic substance—
peroxynitrate [28]. According to the ischemia/reperfusion
concept of glaucomatous damage, if blood supply is
constantly reduced at a moderate level, not leading to
necrosis (for example, in atherosclerosis), the tissue can
adapt to reduced oxygen supply. In case of severe blood
supply reduction, it may lead to infarction of tissue.
However, varying oxygen supply may trigger a cascade of
reperfusion damage as described above. It is at present not
exactly known in which range and on what time scale
ischemia is most productive in causing glaucomatous
damage. The analyzed duration of 5 minutes may well be
too short to capture oscillations of blood flow which would
be of relevance for ischemia/reperfusion damage. However,
even in this arbitrarily chosen short time-frame significant
differences between the groups could be observed, indicat-
ing that regulatory mechanisms both on the ocular
choroidal and on the systemic blood pressure level are
altered in POAG patients compared to those in healthy
controls.
Variability of the two parameters—choroidal blood flow
and systemic blood pressure—seems to be independent one
from the other. No direct intraindividual correlation
between SBP and CBF variability was observed. Variability
was expressed in relative numbers, enabling direct compar-
ison between the two, and the former had a significantly
higher range of variability than the latter. This finding
indicates different and independent sets of regulatory
mechanisms on the ocular and on the systemic level, and
both the choroidal blood flow and the systemic BP
regulation were altered in POAG patients as a group.
However, the correlation between CBF/BP variability and
visual field MD and peripapillary RNFL thickness was not
significant. As no IOP limits were set, both the high-tension
and normal-tension POAG patients were included in the
glaucoma group; hence, various both IOP- and non-IOP-
related pathophysiological mechanismsmay have been at play
in our cohort of POAG patients, which possibly precluded a
statistical association between the local and systemic variabil-
ity of circulation and the actual glaucomatous damage in an
individual patient.
The group of OHT subjects was designed in order to
analyze possible effects of the increased IOP on parameters
of interest. Whereas the OHT group was statistically
equidistant from both the POAG patients and healthy
controls, mean untreated IOP in the OHT group was not
correlated with the variability of the choroidal blood flow,
suggesting a lack of effect of increased IOP on this
parameter.
It is unlikely that the increased variability of choroidal
blood flow was caused by unstable fixation in POAG
patients. In none of the patients was the central fixation
jeopardized by glaucomatous damage. Mean best-corrected
visual acuity was comparable in all three groups (Table 2,
ANOVA p>0.05). No fixation deficit was observed in any
of the examined subjects, as further demonstrated by the
stable DC during the LDF measurements.
In conclusion, short-term variability of choroidal blood
flow and systemic blood pressure are increased in POAG
patients. Further longitudinal studies are necessary to
elucidate possible causal relationships between the analyzed
parameters, and whether manipulation and reduction of
oscillation of perfusion parameters could influence course
of the disease.
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